We are live on ! Find out more
SLS icon

SELLAS Life Sciences
SLS

22 hedge funds and large institutions have $4.28M invested in SELLAS Life Sciences in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,911% more call options, than puts

Call options by funds: $2.77M | Put options by funds: $92K

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

1.41% more ownership

Funds ownership: 9.18% → 10.59% (+1.4%)

1% less capital invested

Capital invested by funds: $4.32M → $4.28M (-$33.4K)

24% less funds holding

Funds holding: 29 → 22 (-7)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
22
Holders Change
-7
Holders Change %
-24.14%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
3
Closed
10
Calls
$2.77M
Puts
$92K
Net Calls
+$2.68M
Net Calls Change
+$746K

Top Buyers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.09M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$101K
3
State Street
State Street
Massachusetts
+$62.8K
4
EH
Equitable Holdings
New York
+$42.1K
5
TRCT
Tower Research Capital (TRC)
New York
+$18.2K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$144K
2
XT
XTX Topco
Cayman Islands
-$131K
3
Morgan Stanley
Morgan Stanley
New York
-$124K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$67.5K
5
VF
Virtu Financial
New York
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
– -$8.35K -3,375 Closed
GRP
27
Global Retirement Partners
California
– -$2.36K -1,000 Closed
Citigroup
28
Citigroup
New York
– -$236 -100 Closed
Bank of America
29
Bank of America
North Carolina
– -$114 -48 Closed
GGI
30
Godsey & Gibb Inc
Virginia
– -$9 -4 Closed
1
2

SLS Hedge Fund Activity: Q1 2023 in Review

22 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q1 2023, worth a combined $4.28M — down 0.77% from $4.32M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of SLS and 3 opened new positions — a net loss of 7 holders — while 3 trimmed existing stakes and 7 added.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $3.09M. The largest seller was Millennium Management, exiting entirely with an estimated $144K sold.

  • 22 institutional investors held SELLAS Life Sciences (SLS) as of Q1 2023, down from 29 in Q4 2022.
  • Funds reported $4.28M of SELLAS Life Sciences stock for Q1 2023, down 0.77% quarter-over-quarter.
  • 3 funds opened new SELLAS Life Sciences positions in Q1 2023 and 10 closed out, a net change of -7 holders.
  • The largest SELLAS Life Sciences buyer in Q1 2023 was Alyeska Investment Group, an estimated $3.09M added.
  • The largest SELLAS Life Sciences seller in Q1 2023 was Millennium Management, an estimated $144K sold.

Based on aggregated 13F filings for Q1 2023.